abbvie AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio By finance.yahoo.com Published On :: 2024-11-12T18:52:44Z Full Article
abbvie AbbVie Drug Expected to Rival Bristol Myers’s New Schizophrenia Med Flunks Phase 2 Test By medcitynews.com Published On :: Mon, 11 Nov 2024 18:25:01 +0000 AbbVie schizophrenia drug candidate emraclidine failed to beat a placebo in two Phase 2 clinical trials. The drug, once projected to compete with Bristol Myers Squibb’s Cobenfy, is from AbbVie’s $8.7 billion acquisition of Cerevel Therapeutics. The post AbbVie Drug Expected to Rival Bristol Myers’s New Schizophrenia Med Flunks Phase 2 Test appeared first on MedCity News. Full Article BioPharma Daily Pharma AbbVie biopharma nl Cerevel Therapeutics Clinical Trials emraclidine schizophrenia
abbvie AbbVie invests in switchable CAR-T therapies for cancer By cen.acs.org Published On :: 25 Jun 2018 11:01:02 +0000 The drug company is partnering with Calibr to develop universal CAR T-cells directed to different tumors via antibody switches Full Article
abbvie AbbVie invests in switchable CAR-T therapies for cancer By cen.acs.org Published On :: 30 Jun 2018 13:13:07 +0000 The drug company is partnering with Calibr to develop universal CAR T cells directed to different tumors via antibody switches Full Article
abbvie Calico and AbbVie advance antiaging efforts By cen.acs.org Published On :: 30 Jun 2018 13:28:29 +0000 Full Article
abbvie AbbVie: Redeploy The Allergan Cash By seekingalpha.com Published On :: Fri, 08 May 2020 12:23:09 -0400 Full Article AGN ABBV Stone Fox Capital
abbvie US regulators permit AbbVie/Allergan merger By www.pharmatimes.com Published On :: Wed, 06 May 2020 12:23:42 +0100 The closing of the acquisition remains subject to other customary closing conditions Full Article
abbvie Ayala hires AbbVie’s Gary Gordon as new CMO By www.pharmafile.com Published On :: Tue, 10 Sep 2019 15:01:39 +0000 AbbVie’s former Vice President of Oncology has moved to Ayala Pharmaceuticals to work as its new Chief Medical Officer (CMO). Israel-based startup Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers – it is currently working on the development of its pan-Notch inhibitor AL101, currently in Phase 2 in adenoid cystic carcinoma (ACC). read more Full Article AbbVie Ayala Research and Development Medical Communications Sales and Marketing Business Services Manufacturing and Production
abbvie FTC clears AbbVie’s $63bn Allergan takeover By www.pmlive.com Published On :: Thu, 07 May 2020 15:48:00 +0100 US regulator satisfied that antitrust concerns are remediated Full Article
abbvie US FTC clears AbbVie’s buy of Allergan, but with divestments By www.thepharmaletter.com Published On :: Wed, 06 May 2020 10:05:00 +0100 Almost a year after the original announcement, the US Federal Trade Commission (FTC) has accepted the… Full Article AbbVie/Allergan/Companies mergers and acquisitions/Endocrinology/Federal Trade Commission/Ireland/Legal/Management/Pancrelipase/Pharmaceutical/USA/Viokace/Zenpep
abbvie BRIEF—AbbVie finally completes acquisition of Allergan By www.thepharmaletter.com Published On :: Sat, 09 May 2020 14:18:00 +0100 US pharma major AbbVie has finally completed its $63 billion acquisition of Ireland-incorporated Allergan,… Full Article AbbVie/Allergan/Companies mergers and acquisitions/Ireland/Legal/Pharmaceutical/USA
abbvie AbbVie CEO: Don't worry, Allergan's aesthetics clients still have money—and 'strong desire' for treatment By www.fiercepharma.com Published On :: Fri, 01 May 2020 15:20:40 +0000 AbbVie may be working through COVID-19, but it's pressing ahead with its Allergan merger, too—and taking stock of products hit by pandemic lockdowns. That puts Allergan’s aesthetics business top of mind, but AbbVie CEO Rick Gonzalez figures customers are ready and able to return quickly for treatment. Full Article
abbvie AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go By www.fiercepharma.com Published On :: Tue, 05 May 2020 17:50:19 +0000 AbbVie and Allergan have waited for nearly a year for their much-discussed merger to pass muster. Finally, after pushback from consumer groups and tight scrutiny from regulators, the FTC has granted its green light. The partners face just one final hurdle to consummating their deal. Full Article
abbvie US regulator clears AbbVie’s $63bn deal for Allergan By www.ft.com Published On :: Wed, 06 May 2020 00:35:56 GMT Federal Trade Commission votes 3-2 to approve tie-up between makers of Botox and Humira Full Article
abbvie AbbVie invests in switchable CAR-T therapies for cancer By feedproxy.google.com Published On :: 25 Jun 2018 11:01:02 +0000 The drug company is partnering with Calibr to develop universal CAR T-cells directed to different tumors via antibody switches Full Article
abbvie AbbVie invests in switchable CAR-T therapies for cancer By feedproxy.google.com Published On :: 30 Jun 2018 13:13:07 +0000 The drug company is partnering with Calibr to develop universal CAR T cells directed to different tumors via antibody switches Full Article
abbvie Calico and AbbVie advance antiaging efforts By feedproxy.google.com Published On :: 30 Jun 2018 13:28:29 +0000 Full Article
